APAL2020D: A randomized phase 3 trial of fludarabine/cytarabine/gemtuzumab ozogamicin with or without venetoclax in children with relapsed AML

Viewing: New Zealand

Filter by

Trial Stage
  • Trial Stage
  • Closed to Recruitment
  • In Development
  • Open
  • Preparing to Open
Location
  • Location
  • New Zealand
  • NSW
  • QLD
  • SA
  • TAS
  • VIC
  • WA
Disease Type
  • Disease Type
  • Bone Cancers (Ewing Sarcoma/Osteosarcoma)
  • Brain and other Central Nervous System (CNS) Tumours
  • Germ Cell Tumours
  • Hodgkin Lymphoma
  • Kidney (Renal) Tumours
  • Leukaemia
  • Liver tumours
  • Neuroblastoma
  • Non-Hodgkin Lymphoma
  • Other
  • Soft Tissue Sarcomas
Disease Stage
  • Disease Stage
  • Newly diagnosed
  • Other
  • Relapsed/Recurrent

APAL2020D: A randomized phase 3 trial...

Leukaemia
Status: Open | New Zealand, QLD, VIC, WA

Relapsed/Recurrent
Read more

ARST1921: A Safety, Pharmacokinetic and Efficacy...

Other
Status: Open | New Zealand

Newly diagnosed, Relapsed/Recurrent
Read more

APAL2020SC: Pediatric Acute Leukemia (PedAL) Screening...

Leukaemia, Other
Status: Open | New Zealand, NSW, QLD, VIC, WA

Relapsed/Recurrent
Read more

BIOMEDE

Status: Closed to Recruitment | New Zealand, NSW, QLD, SA, VIC, WA

Biological Medicine for Diffuse Intrinsic Pontine Glioma Eradication

Newly diagnosed
Read more

rEECur

Bone Cancers (Ewing Sarcoma/Osteosarcoma), Soft Tissue Sarcomas
Status: Open | New Zealand, NSW, QLD, SA, VIC, WA

An international randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma

Relapsed/Recurrent
Read more

LGG-Avastin

Brain and other Central Nervous System (CNS) Tumours
Status: Open | New Zealand, NSW, QLD, SA, VIC, WA

A phase II, open-labeled, multi-center, randomized controlled trial of Vinblastine +/- Bevacizumab (Avastin) for the treatment of chemotherapy-naïve children with unresectable or progressive low grade glioma

Newly diagnosed, Relapsed/Recurrent
Read more

FaR-RMS

Soft Tissue Sarcomas
Status: Open | New Zealand, NSW, VIC, WA

Frontline and Relapse Study in RhabdomyoSarcoma Study

Newly diagnosed, Relapsed/Recurrent
Read more

ReRAD

Brain and other Central Nervous System (CNS) Tumours
Status: Closed to Recruitment | New Zealand, NSW, QLD, VIC, WA

A Phase II Canadian Paediatric Brain Tumour Consortium Study of Re – Irradiation as Treatment of Progressive or Recurrent Diffuse Intrinsic Pontine Glioma

Relapsed/Recurrent
Read more

PNOC-022 (DMG-ACT)

Brain and other Central Nervous System (CNS) Tumours
Status: Open | New Zealand, NSW, QLD, SA, VIC, WA

A Combination Therapy Trial using an Adaptive Platform Design for Children and Young Adults with Diffuse Midline Gliomas including Diffuse Intrinsic Pontine Gliomas at Initial Diagnosis, Post-Radiation Therapy and at Time of Progression.

Newly diagnosed, Relapsed/Recurrent
Read more

All posts loaded.

All posts loaded.

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168

ANZCHOG acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures, and to Elders both past and present. We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi. 

We are committed to creating a safe and welcoming environment that embraces all backgrounds, cultures, sexualities, genders and abilities.